According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A new study shows people taking SGLT-2 inhibitors had fewer dementia cases than those taking DPP-4 inhibitors.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.